Newsfeed

House CR Unveiled With No Doc Fix

House Speaker Mike Johnson, R-LA, unveiled the FFY 2025 continuing resolution (CR) through the end of the fiscal year in September. If the bill passes the House, it goes to the Senate. At least one House GOP member has announced opposition, but the lack of a Medicare physician rate fix could mean others drop off. Passage in the Senate is unknown because 60 votes are needed and Democrats appear to be lining up against it. But moderate Democrats could have a change of heart. The bill also extends some critical healthcare programs that would expire on March 31. The House may vote on the bill Tuesday.

In other news, a bipartisan proposal to further extend telehealth, reform pharmacy benefits managers (PBMs), reverse Medicare physician pay cuts, and address the opioid crisis has failed to be called up in the Senate.

Additional articles: https://insidehealthpolicy.com/daily-news/providers-furious-house-continuing-resolution-omits-doc-pay-fix and https://www.modernhealthcare.com/politics-policy/spending-bill-medicare-doctor-pay and https://thehill.com/homenews/house/5184753-scott-perry-medicaid-coverage/ and https://www.fiercehealthcare.com/telehealth/senate-dems-push-long-shot-bill-pbm-reform-telehealth-extensions-and-35-doc-pay-fix

(Some articles may require a subscription.)

#governmentshutdown #trump #congress #ffy2025 #medicare #physicians #cr

https://www.fiercehealthcare.com/regulatory/speaker-johnson-releases-funding-patch-six-month-telehealth-extension-no-doc-pay-fix

Read More »

Trump May Support Changes To Medicare Drug Negotiations

Big Pharma says that President Donald Trump and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. are sympathetic to the drug lobby’s concerns regarding the Inflation Reduction Act’s (IRA) “pill penalty” provision within the Medicare drug price negotiations.

Drug makers say the law discourages research into small molecule drugs. Small-molecule drugs are exempt from Medicare drug price setting for nine years after FDA approval, while biologics are exempt for 13 years. Big Pharma has been lobbying to extend the small-molecule drug exclusivity period to 13 years.

Some congressional bills would extend the period before price negotiation can begin for small molecule drugs to match biologics.

(Article may require a subscription.)

#ira #drugpricing #branddrugmakers

https://insidehealthpolicy.com/daily-news/pfizer-ceo-trump-kennedy-sympathetic-pill-penalty-concerns

Read More »

Paragon Says Improper Medicaid Payments Could Be Over $1 Trillion

The Paragon Health Institute is an extremely powerful think tank with the ear of the Trump administration and some in Congress. Its newest report, in conjunction with the Economic Policy Innovation Center, says that improper payments under Medicaid could be as much as $1.1 trillion over ten years. The Centers for Medicare and Medicaid Services (CMS) estimated improper payments at $543 billion over ten years, but Paragon says that does not include eligibility check errors.

The report urges Congress to cut funding to states found with greater than 3% erroneous payments based on eligibility errors. Many of the errors are tied to the suspension of eligibility checks during the COVID pandemic. The ineligible population includes people over income limits and illegal immigrants.

The report gives hope that the GOP Congress can reduce Medicaid spending and perhaps certain Medicare spending without fundamentally impacting coverage. This is a promise made by the president and congressional leaders in the House.

(Article may require a subscription.)

#medicaid #fwa #improperpayments

https://insidehealthpolicy.com/daily-news/paragon-epic-eligibility-errors-medicaid-improper-payments-top-11-trillion

Read More »

Budget Reconciliation And DOGE Updates

Two key developments on the spending reduction front. Republican senators met with Elon Musk on his Department of Government Efficiency (DOGE) commission reductions. Many senators, rightists and moderates, told him that Congress must sign off on the reductions. On one hand, the senators were asserting their branch’s constitutional authority. On the other, they said it insulates the DOGE cuts from court attacks. Musk was open to Senate approval but indicated he did not think some of the reductions had to come back to Congress.

He also was surprised that a rescission package can be passed by just a majority vote. Rescission is authorized by the Impoundment Act of 1974. Some House Republicans want to repeal the rescission process to allow the president to exercise what they see as the president’s inherent impoundment authority. It is ironic that the same act could be used to validate DOGE reductions.

GOP senators have expressed frustration with the lack of consultation and Musk’s operating style.

In a second development, the Congressional Budget Office (CBO) said that the House Energy and Commerce Committee cannot reach its $880 billion reduction goal without cutting Medicaid, Medicare, and children’s insurance. GOP leaders say they want to reduce fraud, waste, and abuse (FWA) vs. making major reductions to the Medicaid program.

Additional article: https://thehill.com/homenews/house/5178944-republicans-medicaid-trump-tax-cuts-cbo-finds/?tbref=hp

#doge #budgetreconciliation #congress #trump #spending

https://thehill.com/homenews/senate/5178899-musk-chaired-meeting-restricts-government

Read More »

Tariff Costs Likely Passed Through On Drugs And Medical Devices

Drug and device makers abroad will be levied a tariff if their imported product origin is Mexico, Canada or China and the costs are likely to be passed through to consumers. This means various providers, including hospitals and physicians, will see cost increases. The costs, too, would be passed through in the drug channel, ultimately hitting employer groups, government programs, and consumers. Consumers could see higher premiums as well as cost-sharing hikes. Canada and Mexico will have 25% tariffs under the Trump administration’s announcement this week. China has total tariffs since September of 20% or more as well.

(Article may require a subscription.)

#healthcare #drugpricing #tariffs #hospitals #physicians

https://www.modernhealthcare.com/digital-health/tariffs-mexico-canada-cardinal-intuitive

Read More »

House Dems Run Spending Cut Ads In Swing Districts

A House Democratic campaign organization officially kicked off the 2026 elections by running a television advertising blitz hitting House Republicans over the prospect of Medicaid cuts in budget reconciliation. The ads are running in 23 swing districts in 13 states.

(Article may require a subscription.)

#medicaid #election2026 #budgetreconciliation

https://www.modernhealthcare.com/politics-policy/medicaid-cuts-tv-ads-gop

Read More »

More 2024 Insurance Financial Results

A number of additional health plans announced financial results for 2025.

Clover Health’s stock dipped Feb. 28 after the company announced an earnings per share loss and a 2% miss on quarterly revenue. But the company reported a full-year 2024 adjusted EBITDA of $70 million, a huge year-over-year increase of $112 million.

Alignment Healthcare achieved its first year of positive adjusted EBITDA as a company. It also reported a huge surge in enrollment.

Blue Cross Blue Shield of Massachusetts reported a $400 million operating loss in 2024, driven by spending on GLP-1 medications and other rising medical costs. The company posted a -4.3% operating margin in 2024, compared to a 0.4% margin in 2023. 

In other news, Becker’s reports on Blues’ MA enrollment as well as insurers who gained and lost membership for 2025 in MA.

Additional articles: https://www.fiercehealthcare.com/payers/clover-health-nets-70-million-adjusted-ebitda-misses-revenue-goals and https://www.fiercehealthcare.com/payers/alignment-healthcare-posts-701-million-quarterly-revenue-beats-expectations and https://www.beckerspayer.com/payer/bcbs-massachusetts-reports-400m-loss-driven-by-glp-1-spending.html and https://www.beckerspayer.com/payer/bcbs-plans-ranked-by-medicare-advantage-members-2025.html

#healthplans #medicareadvantage #employercoverage

https://www.beckerspayer.com/payer/which-medicare-advantage-insurers-gained-lost-members-for-2025.html

Read More »

Another Study Shows Impact Of Medicaid Reimbursement Cuts To States

A second study finds the major impact of reducing federal dollars for Medicaid to states. States that expanded Medicaid coverage could have to find $44.3 billion annually in state budget cuts or increased revenue to maintain what they have. The Urban Institute and Robert Wood Johnson Foundation (RWJF) say state spending would be hiked by about 25.6% on average if that occurred. Twelve states have trigger laws that would drop the expansion if the enhanced reimbursement is halted.

I told you yesterday about a Kaiser Family Foundation (KFF) analysis of the spending reductions related to a Medicaid per capita cap program. KFF finds that capping per enrollee spending could reduce federal Medicaid expenditures by $532 billion to nearly $1 trillion over 10 years depending on how states respond. KFF also finds that eliminating the Medicaid expansion matching rate as well could push the federal Medicaid spending savings to as much as $2.1 trillion.

#medicaid #budgetreconciliation #coverage

https://www.healthcaredive.com/news/federal-medicaid-cuts-shift-costs-expansion-states/740966

Read More »

MA Growth Down Markedly In Enrollment Season

The Centers for Medicare and Medicaid Services (CMS) finally published some data on the 2025 enrollment season and growth is down considerably. This is likely tied to the financial crisis in the industry. The January report still seems to have issues so many analysts are either comparing February 2024 to February 2025, January 2024 to February 2025, or a month in late 2024 to February 2025. I will have a comprehensive blog on this subject tomorrow.

Different outlets have ranges of numbers in their coverage. My calculation is that enrollment grew about 4.4% from January 2024 to February 2025. This is down from 8.7% in 2024 and 6.1% in 2022. Of the big nine national health plans, seven gained enrollment from January 2024 to February 2025. But just five of them gained from December 2024 to February 2025.

In other news, the Kaiser Family Foundation (KFF) published an analysis of the spending reductions related to a Medicaid per capita cap program – a possible revamp of Medicaid that stands in between the traditional program we have now and a strict block grant. KFF finds that capping per enrollee spending could reduce federal Medicaid expenditures by $532 billion to nearly $1 trillion over 10 years depending on how states respond. States could either fill the hole or reduce coverage, or a combination. KFF says as many as 15 million could lose coverage by 2034.

KFF also finds that eliminating the Medicaid expansion matching rate as well could push the federal Medicaid spending savings to as much as $2.1 trillion. As many as 30 million could lose coverage if both are done.

Additional articles: https://www.fiercehealthcare.com/payers/cms-data-medicare-advantage-enrollment-growth-hits-skids and https://www.beckerspayer.com/payer/which-medicare-advantage-insurers-gained-lost-members-for-2025.html and https://www.modernhealthcare.com/insurance/medicare-advantage-enrollment-2025 and https://www.kff.org/medicaid/press-release/capping-per-enrollee-spending-could-reduce-federal-medicaid-expenditures-by-532-billion-to-nearly-1-trillion-over-10-years-depending-on-how-states-respond-and-result-in-as-many-as-15-million-people/ and https://www.kff.org/medicaid/issue-brief/a-medicaid-per-capita-cap-state-by-state-estimates/

(Some articles may require a subscription.)

#medicareadvantage #enrollment #medicaid #budgetreconciliation

https://www.healthcaredive.com/news/medicare-advantage-enrollment-2025-unitedhealth-humana/738048/

Read More »

House Passes Budget Framework; Healthcare Cuts Heat Up

The House adopted a budget reconciliation bill today with just one GOP defection. House Speaker Mike Johnson and President Donald Trump got three other doubters to convert to “yes.” The vote was 217 to 215. The bill paves the way for final passage down the road but a great deal of work has to occur, with committees now meeting on spending cut targets. This includes $880 billion in healthcare spending cut targets. Johnson and perhaps Trump convinced holdouts that Medicaid rolls will not be cut except for work requirements and if someone is illegally on the program. It may be hard to keep the commitment with a large reduction bogey. The victory was major for Johnson but he now needs to hold all these folks in place as spending cuts are debated in committees.

Meanwhile, healthcare news is heating up due to the possible spending cuts:

  • The Blue Cross and Blue Shield Association (BSCSA) issued a report today that has $1 trillion in healthcare cost reductions over a decade — federal savings of $524 billion, lower private insurance premiums of $389 billion, patient savings of $180 billion. The largest potential area for savings is to adopt site-neutral payments in Medicare, which would save $484 billion over 10 years. I will do a blog on the report next week.
  • A Modern Healthcare article explains work requirements and their history in Medicaid.
  • The Health and Human Services (HHS) Office of Inspector General (OIG) said that Medicare costs of ten common diabetes medications, including GLP-1s, went up by 364% between 2019 and 2023. In 2019, Medicare spent roughly $7.7 billion. In 2023, the cost reached $35.8 billion.
  • Trump plans to sign an executive order to reinforce rules to make healthcare prices more transparent for patients. The order will update agency enforcement policies to make sure healthcare providers and insurers are complying with the rules.
  • Insurers overall had a poor 2024 due to various issues, including poor Medicare Advantage (MA) rates. There were a few exceptions.
  • A Kaiser Family Foundation (KFF) poll finds that Medicaid is viewed favorably by a large majority (77%) of the public and an even larger share of those on the program (84%). Another poll from Hart Research conducted for the nonprofit Families Over Billionaires finds that 71% percent of voters who backed Trump said cutting Medicaid would be unacceptable. 
  • A compound pharmacy trade group has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug shortage list. Many Americans use these generic compounds for weight loss due to the $1,000 plus cost of brands. Still, the generic drug costs can be $200 plus a month.

Additional articles: https://www.fiercehealthcare.com/regulatory/bcbsa-report-addressing-hospital-pharma-costs-could-save-1t-over-next-decade and https://www.modernhealthcare.com/policy/medicaid-work-requirements-gop-budget and https://www.beckerspayer.com/payer/medicare-part-d-spending-on-weight-loss-drugs-surges-364-oig.html and https://www.modernhealthcare.com/policy/trump-healthcare-cost-transparency and https://www.healthcaredive.com/news/health-insurer-medical-costs-climbing-ma-medicaid/740611/ and https://www.kff.org/medicaid/report/the-debate-over-federal-medicaid-cuts-perspectives-of-medicaid-enrollees-who-voted-for-president-trump-and-vice-president-harris/ and https://thehill.com/policy/healthcare/5161953-obamacare-medicare-budget-entanglement/ and https://thehill.com/homenews/house/5163381-democrats-medicaid-gop-budget/ and https://thehill.com/policy/healthcare/5163193-trump-voters-oppose-medicaid-cuts-poll/\ and https://thehill.com/policy/healthcare/5163570-weight-loss-drugs-fda-shortage-list-ozempic-wegovy/

(Some articles may require a subscription.)

#healthcare #trump #congress #budgetreconciliation #medicare #medicaid #coverage #siteneutral #glp1s #weightlossdrugs #drugpricing #branddrugmakers #healthplans #hospitals #pricetransparency

https://www.cbsnews.com/news/budget-resolution-house-vote-mike-johnson-trump-agenda

Read More »

Available Now

$30.00